{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T17:49:04Z","timestamp":1719251344985},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T00:00:00Z","timestamp":1269129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Patients' understanding of their condition affect the choice of treatment. The aim of this study is to evaluate patients' understanding and treatment preferences before and after an information session on the treatment of acute optic neuritis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Participants were asked to complete a questionnaire consisting of 14 questions before and after an information session presented by a neuro-ophthalmologist. The information session highlighted the treatment options and the treatment effects based on the Optic Neuritis Treatment Trial in plain patient language. The information session stressed the finding that high dose intravenous steroid therapy accelerated visual recovery but does not change final vision and that treatment with oral prednisone alone resulted in a higher incidence of recurrent optic neuritis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Before the information session, 23 (85%) participants knew that there was treatment available for ON and this increased to 27 (100%) after the information session. There were no significantly change in patients knowledge of symptoms of ON and purpose of treatment before and after the information session. Before the information session, 4 (14%) respondents reported they would like to be treated by oral steroid alone in the event of an optic neuritis and 5 (19%) did not respond. After the education session, only 1 patient (4%) indicated they would undergo treatment with oral steroid alone but 25 (92%) indicated they would undergo treatment with intravenous steroid treatment, alone or in combination with oral treatment. Results indicated that there were significant differences in the numbers of participants selecting that they would undergo treatment with a steroid injection (n = 22, p = 0.016).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In this study, patients have shown good understanding of the symptoms and signs of optic neuritis. The finding that significant increases in the likelihood of patients engaging in best practice can be achieved with an information session is very important. This suggests that patient knowledge of available treatments and outcomes can play an important role in implementing and adopting guideline recommendations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2415-10-7","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T07:13:53Z","timestamp":1269328433000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patients' knowledge and perception on optic neuritis management before and after an information session"],"prefix":"10.1186","volume":"10","author":[{"given":"Albert I","family":"Matti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam C","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McCarl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Klaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,21]]},"reference":[{"key":"167_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2008.08.039","volume":"276","author":"V Biousse","year":"2009","unstructured":"Biousse V, Calvetti O, Drews-Botsch CD, Atkins EJ, Sathornsumetee B, Newman NJ, Optic Neuritis Survey Group: Management of optic neuritis and impact of clinical trials: An international survey. J Neuro Sci. 2009, 276: 69-74. 10.1016\/j.jns.2008.08.039.","journal-title":"J Neuro Sci"},{"key":"167_CR2","doi-asserted-by":"publisher","first-page":"A15","DOI":"10.1002\/ana.21249","volume":"63","author":"SC Johnston","year":"2008","unstructured":"Johnston SC, Hauser SL: T2 clinical research: judgment day. Ann Neurol. 2008, 63: A15-6. 10.1002\/ana.21249.","journal-title":"Ann Neurol"},{"key":"167_CR3","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jocn.2008.01.014","volume":"15","author":"CJ Leuck","year":"2008","unstructured":"Leuck CJ, Danesh-Meyer HV, Margrie FJ, Drews-Botsch CD, Calvetti O, Newman NJ, Biousse V: Management of acute optic neuritis: a survey of neurologists and ophthalmologists in Australia and New Zealand. J Clin Neuro. 2008, 15: 1340-1345. 10.1016\/j.jocn.2008.01.014.","journal-title":"J Clin Neuro"},{"key":"167_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/ebm.7.2.36","volume":"7","author":"R Haynes","year":"2002","unstructured":"Haynes R, Devereaux P, Guyatt G: Clinical expertise in the era of evidence-based medicine and patient choice. Evidence-Based Medicine. 2002, 7: 36-38. 10.1136\/ebm.7.2.36.","journal-title":"Evidence-Based Medicine"},{"key":"167_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ijmedinf.2006.05.042","volume":"75","author":"CJ Green","year":"2006","unstructured":"Green CJ, Fortin P, Maclure M, Macgregor A, Robinson S: Information system support as a critical success factor for chronic disease management: Necessary but not sufficient. Int J Med Inform. 2006, 75: 818-28. 10.1016\/j.ijmedinf.2006.05.042.","journal-title":"Int J Med Inform"},{"issue":"Suppl 2","key":"167_CR6","first-page":"116","volume":"254","author":"C Heesen","year":"2007","unstructured":"Heesen C, K\u00f6pke S, Richter T, Kasper J: Shared decision making and self-management in multiple sclerosis--a consequence of evidence. J Neurol. 2007, 254 (Suppl 2): 116-21.","journal-title":"J Neurol"},{"key":"167_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0887-8994(95)00023-9","volume":"12","author":"MI Steinlin","year":"1995","unstructured":"Steinlin MI, Blaser SI, MacGregor DL, Eddy AA, Logan WJ, Laxer RM, Silverman ED: Eye problems in children with multiple sclerosis. Pediatr Neurol. 1995, 12: 207-12. 10.1016\/0887-8994(95)00023-9.","journal-title":"Pediatr Neurol"},{"key":"167_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","volume":"111","author":"JL Keltner","year":"1993","unstructured":"Keltner JL, Johnson CA, Spurr JO, Beck RW: Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol. 1993, 111: 231-4.","journal-title":"Arch Ophthalmol"},{"key":"167_CR9","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Sch\u00fcnemann HJ, Edejer TT, Varonen H, Vist GE, Williams JW, Zaza S, GRADE Working Group: Grading quality of evidence and strength of recommendations. BMJ. 2004, 328: 1490-10.1136\/bmj.328.7454.1490.","journal-title":"BMJ"},{"key":"167_CR10","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1212\/WNL.54.11.2039","volume":"54","author":"DI Kaufman","year":"2000","unstructured":"Kaufman DI, Trobe JD, Eggenberger ER: Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis: Report of the quality standard subcommittee of the American Academy of Neurology. Neurology. 2000, 54: 2039-2044.","journal-title":"Neurology"},{"key":"167_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DI, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR: A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992, 326: 581-8.","journal-title":"N Engl J Med"},{"key":"167_CR12","unstructured":"National Institute for Health and Clinical Excellence. Multiple sclerosis: Management of multiple sclerosis in primary and secondary care. Guideline 8. [http:\/\/www.nice.org.uk\/Guidance\/CG8\/NiceGuidance\/pdf\/English]"},{"key":"167_CR13","first-page":"CD001430","volume":"1","author":"SS Vedula","year":"2007","unstructured":"Vedula SS, Brodney-Folse S, Gal RL, Beck R: Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2007, 1: CD001430-","journal-title":"Cochrane Database Syst Rev"},{"key":"167_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","volume":"49","author":"Optic Neuritis Study Group","year":"1997","unstructured":"Optic Neuritis Study Group: The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology. 1997, 49: 1404-13.","journal-title":"Neurology"},{"key":"167_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ajo.2004.01.040","volume":"137","author":"RW Beck","year":"2004","unstructured":"Beck RW, Gal RL, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Moke PS, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Trobe JD, Wall M, Xing D, Optic Neuritis Study Group: Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol. 2004, 137: 77-83. 10.1016\/j.ajo.2004.01.040.","journal-title":"Am J Ophthalmol"},{"key":"167_CR16","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/archopht.121.2.292","volume":"121","author":"RW Beck","year":"2003","unstructured":"Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Wall M, Optic Neuritis Study Group: High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 2003, 121: 944-9. 10.1001\/archopht.121.7.944.","journal-title":"Arch Ophthalmol"},{"key":"167_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pec.2005.06.002","volume":"62","author":"J Kasper","year":"2006","unstructured":"Kasper J, K\u00f6pke S, M\u00fchlhauser I, Heesen C: Evidence-based patient information about treatment of multiple sclerosis--A phase one study on comprehension and emotional responses. Patient Educ Couns. 2006, 62: 56-63. 10.1016\/j.pec.2005.06.002.","journal-title":"Patient Educ Couns"},{"key":"167_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1352458508095921","volume":"15","author":"S K\u00f6pke","year":"2009","unstructured":"K\u00f6pke S, Kasper J, M\u00fchlhauser I, N\u00fcbling M, Heesen C: Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. Mult Scler. 2009, 15: 96-104. 10.1177\/1352458508095921.","journal-title":"Mult Scler"},{"key":"167_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/jnnp.2006.105759","volume":"78","author":"L Costelloe","year":"2007","unstructured":"Costelloe L, O'Rourke K, Kearney H, McGuigan C, Gribbin L, Duggan M, Daly L, Tubridy N, Hutchinson M: The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). J Neurol Neurosurg Psychiatry. 2007, 78: 841-844. 10.1136\/jnnp.2006.105759.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"167_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/jme.2009.030973","volume":"35","author":"M Schermer","year":"2009","unstructured":"Schermer M: Telecare and self-management: opportunity to change the paradigm?. J Med Ethics. 2009, 35: 688-691. 10.1136\/jme.2009.030973.","journal-title":"J Med Ethics"},{"key":"167_CR21","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0161-6420(99)90482-7","volume":"106","author":"JD Trobe","year":"1999","unstructured":"Trobe JD, Sieving PC, Guire KE, Fredrick AM: The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. Ophthalmology. 1999, 106: 2047-53. 10.1016\/S0161-6420(99)90482-7.","journal-title":"Ophthalmology"},{"key":"167_CR22","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/00005650-199609000-00002","volume":"34","author":"DE Pathman","year":"1996","unstructured":"Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG: The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care. 1996, 34: 873-889. 10.1097\/00005650-199609000-00002.","journal-title":"Med Care"},{"key":"167_CR23","volume-title":"J Gen Intern Med","author":"CA Chong","year":"2009","unstructured":"Chong CA, Chen IJ, Naglie G, Krahn MD: How Well Do Guidelines Incorporate Evidence on Patient Preferences?. J Gen Intern Med. 2009,"},{"key":"167_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1445-5994.2000.tb00832.x","volume":"30","author":"I Scott","year":"2000","unstructured":"Scott I, Heyworth R, Fairweather P: The use of evidence-based medicine in the practice of consultant physicians. Results of a questionnaire survey. Aust N Z J Med. 2000, 30: 319-26.","journal-title":"Aust N Z J Med"},{"key":"167_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/0269215506070805","volume":"20","author":"M Ennis","year":"2006","unstructured":"Ennis M, Thain J, Boggild M, Baker GA, Young CA: A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clin Rehabil. 2006, 20: 783-92.","journal-title":"Clin Rehabil"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-10-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-10-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-10-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-10-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:16:43Z","timestamp":1630495003000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-10-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-10-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,21]]},"assertion":[{"value":"31 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}